Source: United States Senator Kevin Cramer (R-ND)
BISMARCK – U.S. Senators Kevin Cramer (R-ND) and Cindy Hyde-Smith (R-MS), along with 65 of their House and Senate colleagues, filed an amicus brief to support a lawsuit challenging the Food and Drug Administration’s (FDA) approval and deregulation of chemical abortion drugs.
The brief was authored by Americans United for Life and filed in Alliance for Hippocratic Medicine v. FDA, a case before the Northern District of Texas. It contends the FDA failed to adhere to the drug approval process in the Federal Food, Drug, and Cosmetic Act (FFDCA) and waived the pediatric study requirement under the Pediatric Research Equity Act. This brief follows a letter Senator Cramer and 77 of his House and Senate colleagues sent the FDA last month.
“By approving and deregulating chemical abortion drugs, the FDA has not followed Congress’ statutorily prescribed drug approval process and has subverted Congress’ critical public policy interests in upholding patient welfare. The FDA’s lawless actions ultimately endanger women and girls seeking chemical abortions,” stated the brief.
Joining Senators Cramer and Hyde-Smith are Senators Roger Wicker (R-MS), Tommy Tuberville (R-AL), James Lankford (R-OK), Marco Rubio (R-FL), Steve Daines (R-MT), John Thune (R-SD), Mike Braun (R-IN), Markwayne Mullin (R-OK), James Risch (R-ID), John Hoeven (R-ND), and Roger Marshall, M.D. (R-KS). Congressman August Pfluger (R-TX) leads the effort in the House of Representatives.
Stakeholders backing it include SBA Pro-Life America, Catholic Vote, Students for Life Action, Family Policy Alliance, and U.S. Conference of Catholic Bishops.
Click here to read the brief.